EssilorLuxottica seeks to accelerate innovation

EssilorLuxottica has announced the formation of a Scientific Advisory Committee – a move designed to accelerate the company’s ambitions in research areas including ophthalmology, oculomics, optics, audiology, artificial intelligence, physics and ethics.

The global eyewear and eye care company said the committee brings together “some of the world’s most sought-after scientists and thought leaders” spanning science, technology and healthcare. The group will serve as a strategic body offering insights to strengthen EssilorLuxottica’s innovation agenda and support its mission to empower patients and consumers worldwide.

The committee features several internationally-recognised experts including: Professor Alain Aspect, from the Institut d’Optique Graduate School – Université Paris-Saclay and École Polytechnique; Professor Alessio Figalli, director of the Institute for Mathematics Research at ETH Zürich; and Professor Sharon Kujawa, principal investigator at the Eaton-Peabody Laboratories, Mass Eye and Ear.

EssilorLuxottica leadership emphasised the significance of the new advisory body. In a joint statement, Francesco Milleri, chairman and CEO, and  Paul du Saillant, deputy CEO, described the committee as “a defining step” in the company’s innovation journey.

“Building on EssilorLuxottica’s decades of pioneering research and technological breakthroughs, the creation of our first Scientific Advisory Committee marks a defining step in our innovation journey,” they said.

They added: “Engaging with some of the most brilliant minds in science allows us to broaden our horizons, explore uncharted territories and translate knowledge into meaningful human impact. Their expert insights will guide our initiatives to advance ophthalmology, audiology, AI, neuroscience and beyond – amplifying the reach of our solutions across the life sciences. Together we’ll continue to shape the future of our industry, driving transformative progress and reaffirming our commitment to lead with purpose.”